NCBiotech News

We work hard to bring you news about North Carolina’s wide-ranging life sciences community. Please feel free to share it with others. And let us know if you have something we should know about.

The NIH's National Center for Advancing Translational Sciences has announced new SBIR and STTR funding opportunities for entrepreneurs aiming to commercialize innovations.
North Carolina’s entrepreneurial companies had an opportunity to learn more about alternative funding sources through the venture arms of disease foundations at "Invest in Cures," a Larger Than Life Science event series forum.
Durham-based BioAgilytix, a fast-growing provider of bioanalytical testing services for large-molecule drugs, will be acquired by a privately held Belgian investment company.
Fortune 500 medical technology firm acquires Durham-based company and keeps manufacturing of biosurgical sealant device in North Carolina.
The challenge of developing new drugs to treat serious lower gastrointestinal disorders just got easier to digest for Symberix, a Durham biopharmaceutical company.
Advanced Animal Diagnostics (AAD) of Morrisville has entered into a license and commercialization agreement with Zoetis, the world’s largest animal-health company, to bring AAD’s mastitis-detection technology to dairy producers and veterinarians outside of the United States. 
Humacyte, a Durham-based regenerative medicine company, has begun a Phase 2 clinical trial of Humacyl, its bioengineered blood vessel, in patients with vascular trauma.
Durham-based Mycovia Pharmaceuticals, formerly Viamet Pharmaceuticals, has begun two Phase 3 clinical trials of its lead drug candidate for treating recurrent yeast infections in women.
Todd M. Pope, president and CEO of TransEnterix Inc., a Morrisville medical device company that makes minimally invasive robotic surgical systems, has been named to Time magazine’s 50 Most Influential People in Health Care for 2018.
North Carolina’s entrepreneurial companies will have an opportunity to learn more about alternative funding sources -- disease foundations that have established venture arms -- at a November 1 event at the North Carolina Biotechnology Center.
Nufarm Americas has its roots “down under,” but it’s happy to do some of its growing up in the Old North State.
A ranch for horseshoe crabs could soon help corral drug resistant bacteria. It’s the brainchild of a life science team at Greensboro-based Kepley BioSystems.

Because of tropical storm conditions, NCBiotech's RTP office will close at 4:30 p.m. today, Thursday, October 11, 2018.

Check back for additional updates.

 

bluebird bio, a gene therapy company with operations in Durham, has passed a regulatory milestone for its potential treatment of an inherited blood disorder.
RTI International has dedicated a new $67 million headquarters building on its Research Triangle Park campus as it marks its 60th year of business.
scroll back to top of page